Search by Drug Name or NDC

    NDC 59746-0449-30 IRBESARTAN 300 mg/1 Details

    IRBESARTAN 300 mg/1

    IRBESARTAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Jubilant Cadista Pharmaceuticals Inc.. The primary component is IRBESARTAN.

    Product Information

    NDC 59746-0449
    Product ID 59746-449_88691191-8b85-44f3-b802-e170d776ad87
    Associated GPIs 36150030000340
    GCN Sequence Number 034469
    GCN Sequence Number Description irbesartan TABLET 300 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 04750
    HICL Sequence Number 015576
    HICL Sequence Number Description IRBESARTAN
    Brand/Generic Generic
    Proprietary Name IRBESARTAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name IRBESARTAN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name IRBESARTAN
    Labeler Name Jubilant Cadista Pharmaceuticals Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203534
    Listing Certified Through 2024-12-31

    Package

    NDC 59746-0449-30 (59746044930)

    NDC Package Code 59746-449-30
    Billing NDC 59746044930
    Package 30 TABLET in 1 BOTTLE (59746-449-30)
    Marketing Start Date 2015-02-24
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.1844
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description IRBESARTAN 300 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis